Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2681-2690 of 2877 for cancer

Edit search filters
  1. A Study Of Endoscopic Bladder Ultrasound And Core Needle Biopsy

    Rochester, MN

  2. Genetic Biomarker Discovery For Metastatic Prostate Cancer

    Rochester, MN

  3. SBRT For Oligometastatic Castration-Refractory Prostate Cancer

    Rochester, MN

  4. Loneliness In Cancer Patients: A Qualitative Study

    Rochester, MN

  5. Breast Cancer Conditionally Reprogrammed Cell (CRC) Study

    Scottsdale/Phoenix, AZ

  6. Mammographic Density And Breast Cancer Subtypes

    Rochester, MN

  7. A Study Of Women Having Screening Mammography At Mayo Clinic To Develop A Better Way To Predict Risks For Cancer

    Rochester, MN

  8. Cancer Patients' Comfort Answering SO/GI Questions.

    Rochester, MN

  9. Bone Health in Patients with/without Adrenal Disease

    Rochester, MN

  10. Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

.

Mayo Clinic Footer